Bird & Bird has advised Reward, on the strategic investment into the company by Experian plc.

International law firm Bird & Bird has acted as advisor to Reward on the recent strategic investment into the company by Experian plc.

Reward is an industry leader in customer engagement and commerce media, integrating content, advertising, and commerce for consumers through its cloud-based API platform. Experian is a FTSE100 global information services company which delivers a unique combination of data, analytics and software across a wide range of markets including, among others, financial services, healthcare, automotive, agrifinance and insurance. 

Experian’s investment in Reward builds upon an existing commercial partnership between the two companies. Future collaboration will focus on developing further Reward’s offerings across banks and retail and expanding reach, creating a more rewarding experience for consumers.

The Bird & Bird team consisted of partner Jee Ha Kim, senior associate Will Holder, associate Caitlin Cowan and trainee Henry Sealy in Corporate, partner Gavin Punia and senior associate Tom Hepplewhite in Financial Regulation, and Ruth Boardman in Data Privacy.

Jee Ha Kim commented: “We are really pleased to have advised Reward on this exciting investment and believe that this transaction is a fantastic step forward for future collaboration between the two companies. This deal, among many others we have done in the sector, demonstrates Bird & Bird’s exceptional competency in data and consumer tech industry”. 

 

News & Deals

More News & Deals

Deal

Bird & Bird advises World of Women on its transaction to join the Tezos ecosystem

Jul 23 2024

Read More

Deal

Bird & Bird advised EIFFEL GAZ VERT on an investment in the biogas sector

Jul 23 2024

Read More

News

Bird & Bird grows its Finance practice in Italy with the arrival of two new partners

Jul 19 2024

Read More

Deal

Bird & Bird has advised Dopay on its $13.5 million Series A Extension round

Jul 19 2024

Read More

News

Bird & Bird advises iX Biopharma on rights issue

Jul 15 2024

Read More

Deal

Bird & Bird advises HSS on SciRhom’s EUR 63 million Series A financing round

Jul 11 2024

Read More